NDC 82009-139 – Abiraterone
Abiraterone Acetate 250 mg/1 · Tablet · Oral
Product NDC82009-139
Product details
- Brand name
- Abiraterone
- Generic name
- Abiraterone acetate
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA210686
- Marketed since
- October 7, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cytochrome P450 17A1 Inhibitor
Active ingredients
- Abiraterone Acetate 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82009-139-12 | 120 TABLET in 1 BOTTLE (82009-139-12) | Jun 15, 2024 |
Other Abiraterone products
- 68001-489 Abiraterone Acetate 250 mg/1 · Tablet · BluePoint Laboratories
- 68001-673 Abiraterone Acetate 500 mg/1 · Tablet · BluePoint Laboratories
- 82249-010 Abiraterone Acetate 250 mg/1 · Tablet · CivicaScript, LLC
- 0143-9597 Abiraterone Acetate 250 mg/1 · Tablet · Hikma Pharmaceuticals USA Inc.
- 72205-030 Abiraterone Acetate 250 mg/1 · Tablet · Novadoz Pharmaceuticals LLC
- 72789-213 Abiraterone Acetate 250 mg/1 · Tablet · PD-Rx Pharmaceuticals, Inc.
- 72205-284 Abiraterone Acetate 250 mg/1 · Tablet, Film Coated · Novadoz Pharmaceuticals LLC
- 72205-285 Abiraterone Acetate 500 mg/1 · Tablet, Film Coated · Novadoz Pharmaceuticals LLC
- 82009-140 Abiraterone Acetate 500 mg/1 · Tablet, Film Coated · Quallent Pharmaceuticals Health LLC